Comparison of the predictive validity of the mirror chamber and elevated plus maze tests in mice

Journal of Neuroscience Methods

Volumn 188, Issue 1, 2010, Pages 62-70

  Paterson, Neil E ^a   Iwunze, Michelle ^a   Davis, Scott F ^a   Malekiani, Sam A ^a   Hanania, Taleen ^a  

^a PSYCHOGENICS INC   (United States)

Author keywords

Anxiety; Benzodiazepines; Buspirone; Elevated plus maze; Fluoxetine; Locomotor activity; Mirror chamber; Mouse; MPEP; Phenotyping; Predictive validity; Venlafaxine

Indexed keywords

2 METHYL 6 (PHENYLETHYNYL)PYRIDINE; ALPRAZOLAM; BUSPIRONE; CHLORDIAZEPOXIDE; DIAZEPAM; FLUOXETINE; VENLAFAXINE;

ANALYTICAL EQUIPMENT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANXIETY; ARTICLE; BAGG ALBINO MOUSE; C57BL 6 MOUSE; CONTROLLED STUDY; DBA 2 MOUSE; ELEVATED PLUS MAZE TEST; INTERMETHOD COMPARISON; LOCOMOTION; MAZE TEST; MIRROR CHAMBER; MOUSE; NONHUMAN; PHENOTYPE; PREDICTION; PRIORITY JOURNAL; SENSITIVITY ANALYSIS; STRAIN DIFFERENCE; TRANQUILIZING ACTIVITY; VALIDITY;

ANALYSIS OF VARIANCE; ANIMALS; ANTI-ANXIETY AGENTS; ANXIETY; BEHAVIOR, ANIMAL; EXPLORATORY BEHAVIOR; MICE; MOTOR ACTIVITY; PREDICTIVE VALUE OF TESTS;

EID: 77950458348     PISSN: 01650270     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneumeth.2010.02.005     Document Type: Article

References (30)

1. Ballenger J.C. Overview of different pharmacotherapies for attaining remission in generalized anxiety disorder. J Clin Psychiatry 2001, 62(Suppl 19):11-19.
2. Bilkei-Gorzo A., Racz I., Michel K., Zimmer A., Klingmüller D., Zimmer A. Behavioral phenotype of pre-proenkephalin-deficient mice on diverse congenic backgrounds. Psychopharmacology 2004, 176:343-352.
3. Busse C.S., Brodkin J., Tattersall D., Anderson J.J., Warren N., Tehrani L., et al. The behavioral profile of the potent and selective mGlu5 receptor antagonist 3-[(2-methyl-1,3-thiazol-4-yl)ethynyl]pyridine (MTEP) in rodent models of anxiety. Neuropsychopharmacology 2004, 29:1971-1979.
4. Cryan J.F., Holmes A. The ascent of mouse: advances in modelling human depression and anxiety. Nat Rev Drug Discov 2005, 4:775-790.
5. Dulawa S.C., Holick K.A., Gundersen B., Hen R. Effects of chronic fluoxetine in animal models of anxiety and depression. Neuropsychopharmacology 2004, 29:1321-1330.
6. Frye C.A., Sumida K., Dudek B.C., Harney J.P., Lydon J.P., O'Malley B.W., et al. Progesterone's effects to reduce anxiety behavior of aged mice do not require actions via intracellular progestin receptors. Psychopharmacology 2006, 186:312-322.
7. Garrett K.M., Niekrasz I., Haque D., Parker K.M., Seale T.W. Genotypic differences between C57BL/6 and A inbred mice in anxiolytic and sedative actions of diazepam. Behav Genet 1998, 28:125-136.
8. Goyal R., Anil K. Protective effect of alprazolam in acute immobilization stress-induced certain behavioral and biochemical alterations in mice. Pharmacol Rep 2007, 59:284-290.
9. Griebel G., Belzung C., Perrault G., Sanger D.J. Differences in anxiety-related behaviours and in sensitivity to diazepam in inbred and outbred strains of mice. Psychopharmacology 2000, 148:164-170.
10. Hascoët M., Bourin M., Colombel M.C., Fiocco A.J., Baker G.B. Anxiolytic-like effects of antidepressants after acute administration in a four-plate test in mice. Pharmacol Biochem Behav 2000, 65:339-344.
11. Henderson N.D., Turri M.G., DeFries J.C., Flint J. QTL analysis of multiple behavioral measures of anxiety in mice. Behav Genet 2004, 34:267-293.
12. Houri D. Effects of central acting drugs on the mirror staircase test. Nippon Yakurigaku Zasshi 1986, 87:135-142.
13. Katzman M.A. Current considerations in the treatment of generalized anxiety disorder. CNS Drugs 2009, 23:103-120.
14. Kaur G., Kulkarni S.K. Differential effect of a polyherbal formulation-OB-200G in male and female mice subjected to forced swim stress. Indian J Physiol Pharmacol 2000, 44:281-289.
15. Kim S., Lee S., Ryu S., Suk J., Park C. Comparative analysis of the anxiety-related behaviors in four inbred mice. Behav Processes 2002, 60:181-190.
16. Kliethermes C.L., Finn D.A., Crabbe J.C. Validation of a modified mirrored chamber sensitive to anxiolytics and anxiogenics in mice. Psychopharmacology 2003, 169:190-197.
17. Kulkarni S.K., Singh K., Bishnoi M. Elevated zero maze: a paradigm to evaluate antianxiety effects of drugs. Methods Find Exp Clin Pharmacol 2007, 29:343-348.
18. Kumar A., Garg R. A role of nitric oxide mechanism involved in the protective effects of venlafaxine in sleep deprivation. Behav Brain Res 2008, 194:169-173.
19. Lamberty Y. The mirror chamber test for testing anxiolytics: is there a mirror-induced stimulation?. Physiol Behav 1998, 64:703-705.
20. Moreau J.L., Jenck F., Pieri L., Schoch P., Martin J.R., Haefely W.E. Physical dependence induced in DBA/2J mice by benzodiazepine receptor full agonists, but not by the partial agonist Ro 16-6028. Eur J Pharmacol 1990, 190:269-273.
21. 2 receptor subtypes in the mechanism of action of antidepressants in the four plates test. Psychopharmacology 2005, 179:418-429.
22. National Institutes of Health. 1996. Principles of Laboratory Animal Care. 1996.
23. Robertson H.A. Audiogenic seizures: increased benzodiazepine receptor binding in a susceptible strain of mice. Eur J Pharmacol 1980, 66:249-252.
24. Rodgers R.J. Animal models of 'anxiety': where next?. Behav Pharmacol 1997, 8(6-7):477-496.
25. Spencer C.M., Alekseyenko O., Serysheva E., Yuva-Paylor L.A., Paylor R. Altered anxiety-related and social behaviors in the Fmr1 knockout mouse model of fragile X syndrome. Genes Brain Behav 2005, 4:420-430.
26. Toubas P.L., Abla K.A., Cao W., Logan L.G., Seale T.W. Latency to enter a mirrored chamber: a novel behavioral assay for anxiolytic agents. Pharmacol Biochem Behav 1990, 35:121-126.
27. Turri M.G., Datta S.R., DeFries J., Henderson N.D., Flint J. QTL analysis identifies multiple behavioral dimensions in ethological tests of anxiety in laboratory mice. Curr Biol 2001, 11:725-734.
28. Varty G.B., Grilli M., Forlani A., Fredduzzi S., Grzelak M.E., Guthrie D.H., et al. The antinociceptive and anxiolytic-like effects of the metabotropic glutamate receptor 5 (mGluR5) antagonists, MPEP and MTEP, and the mGluR1 antagonist, LY456236, in rodents: a comparison of efficacy and side-effect profiles. Psychopharmacology 2005, 179:207-217.
29. Walf A.A., Koonce C., Manley K., Frye C.A. Proestrous compared to diestrous wild-type, but not estrogen receptor beta knockout, mice have better performance in the spontaneous alternation and object recognition tasks and reduced anxiety-like behavior in the elevated plus and mirror maze. Behav Brain Res 2009, 196:254-260.
30. Westenberg H.G. Recent advances in understanding and treating social anxiety disorder. CNS Spectr 2009, 14:24-33.